Dietary sugar and carbohydrate intakes will be manipulated for 3 days in a randomised crossover design. All food will be provided. Free-living physical activity energy expenditure will be measured using combined heart rate and accelerometry. Metabolic and appetite/mood responses to 3 days on each diet will be measured. Each participant will undergo 3 days of each diet: 1. Moderate sugar - reflecting the composition of a typical European diet 2. Low sugar - similar macronutrient composition of a typical European diet but with \<5% energy intake from free sugars (as per government guidelines) 3. Low carbohydrate - low carbohydrate diet with \<5% energy intake from sugar and \<8% energy intake from carbohydrate, replacing carbohydrate energy with fat
Guidelines calling for dietary free sugars to be reduced have been formulated from evidence that diets high in sugar are associated with high energy intake. In theory, by reducing the intake of sugars, calorie surplus will be reduced and energy balance will be maintained. However, when referring to interventions/behaviours that influence energy balance, both sides of the energy balance equation need to be considered. Alterations in nutrients may influence aspects of energy expenditure, not solely energy intake, and this may have implications for the efficacy of guidelines seeking to influence energy intake. It is important to consider energy expenditure in the context of health. The most variable component of energy expenditure between individuals is physical activity energy expenditure (PAEE), which varies from \~600-2100 kcal per day in men of a similar demographic. Current guidelines do not regard the effect that changing dietary sugar might have on PAEE and therefore total energy expenditure. Furthermore, there is increasing interest in restricting overall carbohydrate intake to treat metabolic disease or achieve ketogenesis. Very little is known about nutrition-physical activity interactions with this type of intervention. This study will prescribe 3 diets to healthy males for 3 days in a randomised crossover design, where each participant will consume each of the diets. All food will be prepared and provided by the study team. The diets are as follows: 1. Moderate sugar - reflecting the composition of a typical European diet 2. Low sugar - similar macronutrient composition of a typical European diet but with \<5% energy intake from free sugars (as per government guidelines) 3. Low carbohydrate - low carbohydrate diet with \<5% energy intake from sugar and \<8% energy intake from carbohydrate, replacing carbohydrate energy with fat
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Enrollment
25
Macronutrient composition (specifically type and/or amount of carbohydrate) is manipulated
University of Bath
Bath, Somerset, United Kingdom
Physical activity energy expenditure (kj/day or kcal/day)
Physical activity energy expenditure measured using individually-calibrated combined heart rate and accelerometry (kj/day or kcal/day)
Time frame: 3 days
Time spent in different physical activity intensities (MET categories) (minutes)
Time spent in different physical activity intensities (MET categories) (minutes) using individually-calibrated combined heart rate and accelerometry
Time frame: 3 days
Energy expended in different physical activity intensities (MET categories) (kJ/day or kcal/day)
Energy expended in different physical activity intensities (MET categories) (kJ/day or kcal/day) using individually-calibrated combined heart rate and accelerometry
Time frame: 3 days
Energy expended in the postprandial period (kJ or kcal)
Energy expended in the postprandial period (kJ or kcal) measured using individually-calibrated combined heart rate and accelerometry
Time frame: 3 days
Fasting blood glucose concentrations
Measures of blood glucose concentrations pre- and post-intervention.
Time frame: 3 days
Fasting blood insulin concentrations
Measures of blood insulin concentrations pre- and post-intervention.
Time frame: 3 days
Fasting blood triglyceride concentrations
Measures of blood triglyceride concentrations pre- and post-intervention.
Time frame: 3 days
Fasting blood non-esterified fatty acid concentrations
Measures of blood non-esterified fatty acid concentrations pre- and post-intervention.
Time frame: 3 days
Fasting blood lactate concentrations
Measures of blood lactate concentrations pre- and post-intervention.
Time frame: 3 days
Fasting blood beta-hydroxybutyrate concentrations
Measures of blood beta-hydroxybutyrate concentrations pre- and post-intervention.
Time frame: 3 days
Fasting blood leptin concentrations
Measures of blood leptin concentrations pre- and post-intervention.
Time frame: 3 days
Fasting blood fibroblast growth factor-21 concentrations
Measures of blood fibroblast growth factor-21 concentrations pre- and post-intervention.
Time frame: 3 days
Fasting blood total cholesterol concentrations
Measures of blood total cholesterol concentrations pre- and post-intervention.
Time frame: 3 days
Fasting blood high density lipoprotein concentrations
Measures of blood high density lipoprotein concentrations pre- and post-intervention.
Time frame: 3 days
Fasting blood low density lipoprotein concentrations
Measures of blood low density lipoprotein concentrations pre- and post-intervention.
Time frame: 3 days
Food preference ratings
Food preference ratings determined by computer task measured pre- and post-intervention
Time frame: 3 days
Subjective appetite and mood ratings
Measured by 0-100 mm visual analogue scales measured pre- and post-intervention
Time frame: 3 days
Blood pressure
Blood pressure using an automated sphygmomanometer pre- and post-intervention
Time frame: 3 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.